risperidone

"Extended" (Alternate Day) Antipsychotic Dosing

Effect of Cognitive Behavioral Therapy on Auditory Hallucinations and NLR in Schizophrenia Patients

Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders

Cerebellum-based Imaging Neural Markers for Antipsychotic Response

Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients

CLOZAPINE Response in Biotype-1

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use

A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia

Study of a Novel Antipsychotic ITI-007 in Schizophrenia

A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone

Adjunctive iTBS for First-Episode Schizophrenia

the Effect of Formulation on Anxiety in Autist Childre A Randomized Controlled Trial Assesses Spirulina Syrup Plus Risperidone in Children With Non-idiopathic Autism. Anxiety is Measured Using the SCAS (Parent Version) Via Daily Online Surveys for One Week and Throughout a 3-month Follow-up Period.

Biomarkers to Enhance Early Schizophrenia Treatment

Risperidone for the Treatment of Huntington's Disease Involuntary Movements

Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine

Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant

A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication